alprazolam has been researched along with gsk 561679 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, A; Ernst, M; Grillon, C; Hale, E; Lieberman, L; Pine, DS | 1 |
1 trial(s) available for alprazolam and gsk 561679
Article | Year |
---|---|
The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.
Topics: Acoustic Stimulation; Adult; Alprazolam; Anti-Anxiety Agents; Anticipation, Psychological; Anxiety; Azabicyclo Compounds; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Electroshock; Fear; Female; Humans; Neuropsychological Tests; Oxadiazoles; Psychotropic Drugs; Receptors, Corticotropin-Releasing Hormone; Reflex, Startle; Surveys and Questionnaires; Uncertainty | 2015 |